Skip to content

Effects of Intrathecal Hydromorphone on Acute Postoperative Pain Following Abdominal Surgery

Effects of Intrathecal Hydromorphone on Acute Postoperative Pain Following Abdominal Surgery

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600128746
Enrollment
Unknown
Registered
2026-07-24
Start date
2026-09-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diseases requiring abdominal surgery, including gastric, intestinal and hepatic tumors, hepatolithiasis, uterine fibroids, uterine and ovarian neoplasms, etc.

Interventions

Intrathecal group:Intrathecal hydromorphone group
TAP group:Ultrasound-guided abdominal transversus abdominis plane block with 60ml 0.2% ropivacaine

Sponsors

The First People's Hospital Of Longquanyi District Chengdu
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. age >= 18 years; 2. American Society of Anesthesiologists (ASA) physical status classification I to III; 3. patients undergoing elective abdominal surgery graded III–IV with an operation duration of no less than 2 hours.

Exclusion criteria

Exclusion criteria: 1. BMI =30 kg/m²; 2. Patients with contraindications to neuraxial procedures, including those with coagulation disorders (defined as platelet count 1.5, or current anticoagulant use), spinal deformities, a history of spinal trauma or spinal surgery, severe chronic lumbago, infection at the puncture site, or radiologically confirmed osseous tumor metastasis; 3. Patients with severe comorbidities such as hepatic or renal insufficiency, cardiac or respiratory dysfunction, and those expected to be transferred to the ICU postoperatively; 4. Patients with chronic pain or chronic opioid exposure (opioid use for >=3 months daily, or morphine >=60 mg/d for at least 1 month); 5. Allergy to any study-related medications; 6. Patients with language barriers who cannot understand preoperative education, assessment scales, or the operation procedure of analgesic pumps; 7. Participation in another clinical trial within 3 months prior to enrollment in this study.

Design outcomes

Primary

MeasureTime frame
Cumulative pain intensity during mobilization within the first 24 h postoperatively;

Secondary

MeasureTime frame
Cumulative pain intensity during mobilization within the 48and 72h postoperatively;adverse effect;Postoperative recovery outcomes;

Countries

China

Contacts

Public ContactLiu Hongxin

The First People's Hospital Of Longquanyi District Chengdu

17778392160@qq.com+86 28 6823 8360

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 10, 2026